ChromaDex develops nutraceuticals for aging, Their flagship product Tru Niagen. ChromaDex has used their formulations in many clinical trials supporting the use of nicotinamide riboside (NR). ChromaDex boasts that approximately 70% of clinical trials using NR have used ChromaDex’s formulations. Rober Fried is the current CEO of ChromaDex.
×
ChromaDex � Niagen
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD